Histopathology and proteomics are synergistic for high-grade serous ovarian cancer platinum response prediction

Abstract Patients with High-Grade Serous Ovarian Cancer (HGSOC) exhibit varied responses to treatment, with 20–30% showing de novo resistance to platinum-based chemotherapy. While hematoxylin-eosin (H&E)-stained pathological slides are used for routine diagnosis of cancer type, they may also contain...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Oz Kilim, Alex Olar, András Biricz, Lilla Madaras, Péter Pollner, Zoltán Szállási, Zsofia Sztupinszki, István Csabai
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	Nature Portfolio 2025-01-01
Rangatū:	npj Precision Oncology
Urunga tuihono:	https://doi.org/10.1038/s41698-025-00808-w
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!